| Neurocysticercosis. Short course of treatment with albendazole. | |
| | |
MedLine Citation:
|
PMID: 2818259 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Eighteen patients with nonenhancing parenchymal brain cysts were treated with albendazole; 9 patients were treated for 3 days and 9 patients for 1 month at daily doses of 15 mg/kg of body weight. Three months after starting therapy, results showed that in both groups the treatment was highly effective. Control studies carried out in the same group before the trial did not show any significant improvement. Five patients were controls and were treated only with symptomatic drugs. The total diameter of the lesions was reduced from 220.1 mm to 52.1 mm, which signifies a reduction of 76.3% in patients treated for a period of 3 days, and from 278.5 mm to 82.1 mm, which is 70.5%, in patients treated for 30 days. We conclude that albendazole administered according to the 3-day therapeutic scheme proposed above is as highly effective for the treatment of parenchymal brain cysticercosis as the 30-day scheme. |
| | |
Authors:
|
F Alarcón; L Escalante; G Dueñas; M Montalvo; M Román |
Related Documents
:
|
19156519 - Variation in colonoscopic technique and adenoma detection rates at an academic gastroen... 9329359 - Effect of octreotide pretreatment on surgical outcome in acromegaly. 3300159 - Clinical experience with authentic recombinant somatropin--german collaborative study. 10865479 - The natural history of untreated vestibular schwannomas. is there a role for conservati... 10728629 - Persistent increase of prl after oral contraceptive treatment. alterations in dopaminer... 20494159 - Assessing pest control using changes in instantaneous rate of population increase: trea... 10981569 - Randomised, placebo-controlled study of the postoperative analgesic effects of ketoprof... 18498829 - A novel anatomy-conforming metallic stent for tracheobronchial stenosis. 17442449 - Post-operative respiratory rehabilitation after lung resection for non-small cell lung ... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Archives of neurology Volume: 46 ISSN: 0003-9942 ISO Abbreviation: Arch. Neurol. Publication Date: 1989 Nov |
Date Detail:
|
Created Date: 1989-12-12 Completed Date: 1989-12-12 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 0372436 Medline TA: Arch Neurol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 1231-6 Citation Subset: AIM; IM |
Affiliation:
|
Department of Neurology, Eugenio Espejo Hospital, Quito, Ecuador. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Albendazole / therapeutic use* Brain Diseases / cerebrospinal fluid, drug therapy*, radiography Cysticercosis / cerebrospinal fluid, drug therapy*, radiography Female Humans Male Middle Aged Tomography, X-Ray Computed |
| Chemical | |
Reg. No./Substance:
|
54965-21-8/Albendazole |
| Comments/Corrections | |
Comment In:
|
Arch Neurol. 1990 Dec;47(12):1278-9
[PMID:
2252445
]
Arch Neurol. 1990 Oct;47(10):1059-60 [PMID: 2222234 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration.
Next Document: Left ventricular thrombus and systemic emboli complicating the cardiomyopathy of Duchenne's muscular...